ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Recent Registrations
     ProductPackage SizeEFPCPSBDCCompositionRegistr. HolderCategory    
January - February - March - April - May - June - July - August - September - Oktober - November - December | 2002 - 2003 - 2004 - 2005 - 2006 - 2007 - 2008 - 2009 - 2010 - 2011 - 2012 - 2013 - 2014 - 2015 - 2016 - 2017 - 2018 - 2019 - 2020 - 2021 - 2022 - 2023 - 2024 - 2025
August 2016 - 105 products
   CI Selomida Haut7.5 gPRPRk.A.Pulver zur Herstellung einer Lösung zum Einnehmen: 3 Active AgentsSchwabe Pharma AGDGtell a friend
  IPCI Oxycodon-Naloxon-Mepha 5
mg/2.5 mg		309.1326.3510 %Delayed release tablets: 2 Active AgentsMepha Pharma AGA+ / SL / SGGtell a friend
  IPCI Oxycodon-Naloxon-Mepha 5
mg/2.5 mg		6016.0633.9010 %Delayed release tablets: 2 Active AgentsMepha Pharma AGA+ / SL / SGGtell a friend
  IPCI Oxycodon-Naloxon-Mepha 10
mg/5 mg		3013.9431.6010 %Delayed release tablets: 2 Active AgentsMepha Pharma AGA+ / SL / SGGtell a friend
  IPCI Oxycodon-Naloxon-Mepha 10
mg/5 mg		6024.5143.0510 %Delayed release tablets: 2 Active AgentsMepha Pharma AGA+ / SL / SGGtell a friend
  IPCI Oxycodon-Naloxon-Mepha 20
mg/10 mg		3023.5142.0010 %Delayed release tablets: 2 Active AgentsMepha Pharma AGA+ / SL / SGGtell a friend
  IPCI Oxycodon-Naloxon-Mepha 20
mg/10 mg		6044.9465.3010 %Delayed release tablets: 2 Active AgentsMepha Pharma AGA+ / SL / SGGtell a friend
  IPCI Oxycodon-Naloxon-Mepha 40
mg/20 mg		3043.5363.7510 %Delayed release tablets: 2 Active AgentsMepha Pharma AG● A+ / SL / SGGtell a friend
  IPCI Oxycodon-Naloxon-Mepha 40
mg/20 mg		6084.08107.8510 %Delayed release tablets: 2 Active AgentsMepha Pharma AG● A+ / SL / SGGtell a friend
L IPCI Pramipexol ER Sandoz
0.375 mg		104.5314.1510 %Delayed release tablets: Pramipexoli Dihydrochloridum MonohydricumSandoz
Pharmaceuticals AG		● B / SL / SGGtell a friend
L IPCI Pramipexol ER Sandoz 0.75 mg108.3825.5510 %Delayed release tablets: Pramipexoli Dihydrochloridum MonohydricumSandoz
Pharmaceuticals AG		B / SL / SGGtell a friend
L IPCI Pramipexol ER Sandoz 0.75 mg3023.3941.8510 %Delayed release tablets: Pramipexoli Dihydrochloridum MonohydricumSandoz
Pharmaceuticals AG		● B / SL / SGGtell a friend
L IPCI Pramipexol ER Sandoz 1.5 mg3046.7867.3010 %Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum 1.5 mgSandoz
Pharmaceuticals AG		● B / SL / SGGtell a friend
L IPCI Pramipexol ER Sandoz 3 mg3093.57118.2010 %Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum 3 mgSandoz
Pharmaceuticals AG		● B / SL / SGGtell a friend
L IPCI Pramipexol ER Sandoz 4.5 mg30140.36169.0510 %Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum 4.5 mgSandoz
Pharmaceuticals AG		B / SL / SGGtell a friend
L IPCI Pramipexol-Mepha ER 0.375 mg104.5314.1510 %Delayed release tablets: Pramipexoli Dihydrochloridum MonohydricumMepha Pharma AGB / SL / SGGtell a friend
L IPCI Pramipexol-Mepha ER 0.75 mg108.3825.5510 %Delayed release tablets: Pramipexoli Dihydrochloridum MonohydricumMepha Pharma AGB / SL / SGGtell a friend
L IPCI Pramipexol-Mepha ER 0.75 mg3023.3941.8510 %Delayed release tablets: Pramipexoli Dihydrochloridum MonohydricumMepha Pharma AGB / SL / SGGtell a friend
L IPCI Pramipexol-Mepha ER 1.5 mg3046.7867.3010 %Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum 1.5 mgMepha Pharma AGB / SL / SGGtell a friend
L IPCI Pramipexol-Mepha ER 3 mg3093.56118.1510 %Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum 3 mgMepha Pharma AGB / SL / SGGtell a friend
L IPCI Pramipexol-Mepha ER 4.5 mg30140.34169.0510 %Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum 4.5 mgMepha Pharma AGB / SL / SGGtell a friend
  IPCI Candesartan Spirig HC 4 mg102.1411.5510 %Tablets: Candesartanum Cilexetilum 4 mgSpirig HealthCare AGB / SL / SGGtell a friend
  IPCI Candesartan Spirig HC 8 mg307.2317.1010 %Tablets: Candesartanum Cilexetilum 8 mgSpirig HealthCare AGB / SL / SGGtell a friend
  IPCI Candesartan Spirig HC 8 mg10022.6041.0010 %Tablets: Candesartanum Cilexetilum 8 mgSpirig HealthCare AGB / SL / SGGtell a friend
  IPCI Candesartan Spirig HC 16 mg308.7325.9010 %Tablets: Candesartanum Cilexetilum 16 mgSpirig HealthCare AGB / SL / SGGtell a friend
  IPCI Candesartan Spirig HC 16 mg10029.3848.3510 %Tablets: Candesartanum Cilexetilum 16 mgSpirig HealthCare AGB / SL / SGGtell a friend
  IPCI Candesartan Spirig HC 32 mg3013.2330.8010 %Tablets: Candesartanum Cilexetilum 32 mgSpirig HealthCare AGB / SL / SGGtell a friend
  IPCI Candesartan Spirig HC 32 mg10041.5361.5510 %Tablets: Candesartanum Cilexetilum 32 mgSpirig HealthCare AGB / SL / SGGtell a friend
L IPCI Acarizax3077.30100.5010 %ALK-Abelló AGA / SLGtell a friend
L IPCI Acarizax90231.92268.6510 %ALK-Abelló AGA / SLGtell a friend
L IP PPIdelvion 250 IU250 IE529.27584.0510 %CSL Behring Lengnau AGB / SLGtell a friend
L IP PPIdelvion 500 IU500 IE1058.531127.1010 %CSL Behring Lengnau AGB / SLGtell a friend
L IP PPIdelvion 1000 IU1000 IE2117.062213.1510 %CSL Behring Lengnau AGB / SLGtell a friend
L IP PPIdelvion 2000 IU2000 IE4234.124385.2510 %CSL Behring Lengnau AGB / SLGtell a friend
  IPCI Mezavant, 1,2 g
magensaftresistente
Retardtabletten		6047.3267.9010 %Mesalazinum 1.2 gTakeda Pharma AGB / SLGtell a friend
L IP PPIdelvion 3500 IU3500 IE7409.717643.4010 %Lyophilisate and solvent: Albutrepenonacogum Alfa 3500 UICSL Behring Lengnau AGB / SLGtell a friend
L IPCI Adenuric 80 mg1412.8830.4010 %Coated tablets: Febuxostatum 80 mgA. Menarini GmbHB / SLGtell a friend
L IPCI Adenuric 80 mg2825.4344.0510 %Coated tablets: Febuxostatum 80 mgA. Menarini GmbHB / SLGtell a friend
L IPCI Adenuric 80 mg9882.57106.2010 %Coated tablets: Febuxostatum 80 mgA. Menarini GmbHB / SLGtell a friend
L IPCIPPUptravi 200 mcg604448.374854.3010 %Coated tablets: SelexipagumActelion
Pharmaceuticals Ltd		B / SLGtell a friend
L IPCIPPUptravi 200 mcg1409029.519572.1010 %Coated tablets: SelexipagumActelion
Pharmaceuticals Ltd		B / SLGtell a friend
L IPCIPPUptravi 400 mcg604448.374854.3010 %Coated tablets: SelexipagumActelion
Pharmaceuticals Ltd		B / SLGtell a friend
L IPCIPPUptravi 600 mcg604448.374854.3010 %Coated tablets: SelexipagumActelion
Pharmaceuticals Ltd		B / SLGtell a friend
L IPCIPPUptravi 800 mcg604448.374854.3010 %Coated tablets: SelexipagumActelion
Pharmaceuticals Ltd		B / SLGtell a friend
L IPCIPPUptravi 1000 mcg604448.374854.3010 %Coated tablets: Selexipagum 1 mgActelion
Pharmaceuticals Ltd		B / SLGtell a friend
L IPCIPPUptravi 1200 mcg604448.374854.3010 %Coated tablets: Selexipagum 1.2 mgActelion
Pharmaceuticals Ltd		B / SLGtell a friend
L IPCIPPUptravi 1400 mcg604448.374854.3010 %Coated tablets: Selexipagum 1.4 mgActelion
Pharmaceuticals Ltd		B / SLGtell a friend
L IPCIPPUptravi 1600 mcg604448.374854.3010 %Coated tablets: Selexipagum 1.6 mgActelion
Pharmaceuticals Ltd		B / SLGtell a friend
  IPCI Nevanac 3 mg / ml3 ml12.7330.2510 %Augentropfensuspension: Nepafenacum 3 mg/mlNovartis Pharma
Schweiz AG		B / SLGtell a friend
L IP  Kovaltry 500 I.E. 363.97414.4510 %Pulver und Lösungsmittel zur Herstellung einer Injektions- oder Infusionslösung: Factor Viii Coagulationis Humanus 500 UIBayer (Schweiz) AGB / SLGtell a friend
L IP  Kovaltry 1000 I.E. 727.49787.4510 %Pulver und Lösungsmittel zur Herstellung einer Injektions- oder Infusionslösung: Factor Viii Coagulationis Humanus 1000 UIBayer (Schweiz) AGB / SLGtell a friend
L IP  Kovaltry 2000 I.E. 1451.351530.1510 %Pulver und Lösungsmittel zur Herstellung einer Injektions- oder Infusionslösung: Factor Viii Coagulationis Humanus 2000 UIBayer (Schweiz) AGB / SLGtell a friend
  IP  ChloraPrep coloré,
solution pour application
cutanée avec 3.0 ml
applicateur		3 mlPRPRk.A.2 Active AgentsBD Switzerland Sàrl
Business Park Terre-
Bonne, Bâtiment A4		DGtell a friend
  IP  ChloraPrep coloré,
solution pour application
cutanée avec 10.5 ml
applicateur		10.5 mlPRPRk.A.2 Active AgentsBD Switzerland Sàrl
Business Park Terre-
Bonne, Bâtiment A4		DGtell a friend
  IP  ChloraPrep coloré,
solution pour application
cutanée avec 26 ml
applicateur		26 mlPRPRk.A.2 Active AgentsBD Switzerland Sàrl
Business Park Terre-
Bonne, Bâtiment A4		DGtell a friend
  IP  ChloraPrep coloré,
solution pour application
cutanée avec 3.0 ml
applicateur		25 x 3 mlPRPRk.A.2 Active AgentsBD Switzerland Sàrl
Business Park Terre-
Bonne, Bâtiment A4		DGtell a friend
  IP  ChloraPrep coloré,
solution pour application
cutanée avec 10.5 ml
applicateur		25 x 10.5 mlPRPRk.A.2 Active AgentsBD Switzerland Sàrl
Business Park Terre-
Bonne, Bâtiment A4		DGtell a friend
  IPCIPPStrensiq 40 mg/ml PRPRk.A.Injection solution: Asfotasum Alfa 40 mg/mlAlexion Pharma GmbHAGtell a friend
  IPCIPPStrensiq 40 mg/ml PRPRk.A.Injection solution: Asfotasum Alfa 40 mg/mlAlexion Pharma GmbHAGtell a friend
  IPCIPPStrensiq 40 mg/ml PRPRk.A.Injection solution: Asfotasum Alfa 40 mg/mlAlexion Pharma GmbHAGtell a friend
  IPCIPPStrensiq 40 mg/ml PRPRk.A.Injection solution: Asfotasum Alfa 40 mg/mlAlexion Pharma GmbHAGtell a friend
  IPCIPPStrensiq 40 mg/ml PRPRk.A.Injection solution: Asfotasum Alfa 40 mg/mlAlexion Pharma GmbHAGtell a friend
  IPCIPPStrensiq 40 mg/ml PRPRk.A.Injection solution: Asfotasum Alfa 40 mg/mlAlexion Pharma GmbHAGtell a friend
  IPCIPPStrensiq 40 mg/ml PRPRk.A.Injection solution: Asfotasum Alfa 40 mg/mlAlexion Pharma GmbHAGtell a friend
  IPCIPPStrensiq 40 mg/ml PRPRk.A.Injection solution: Asfotasum Alfa 40 mg/mlAlexion Pharma GmbHAGtell a friend
  IPCIPPStrensiq 40 mg/ml12PRPRk.A.Injection solution: Asfotasum Alfa 40 mg/mlAlexion Pharma GmbHAGtell a friend
  IPCIPPStrensiq 40 mg/ml12PRPRk.A.Injection solution: Asfotasum Alfa 40 mg/mlAlexion Pharma GmbHAGtell a friend
  IPCIPPStrensiq 40 mg/ml12PRPRk.A.Injection solution: Asfotasum Alfa 40 mg/mlAlexion Pharma GmbHAGtell a friend
  IPCIPPStrensiq 40 mg/ml12PRPRk.A.Injection solution: Asfotasum Alfa 40 mg/mlAlexion Pharma GmbHAGtell a friend
  IPCIPPStrensiq 40 mg/ml12PRPRk.A.Injection solution: Asfotasum Alfa 40 mg/mlAlexion Pharma GmbHAGtell a friend
  IPCIPPStrensiq 40 mg/ml12PRPRk.A.Injection solution: Asfotasum Alfa 40 mg/mlAlexion Pharma GmbHAGtell a friend
  IPCIPPStrensiq 40 mg/ml12PRPRk.A.Injection solution: Asfotasum Alfa 40 mg/mlAlexion Pharma GmbHAGtell a friend
  IPCIPPStrensiq 40 mg/ml12PRPRk.A.Injection solution: Asfotasum Alfa 40 mg/mlAlexion Pharma GmbHAGtell a friend
  IPCIPPStrensiq 100 mg/ml PRPRk.A.Injection solution: Asfotasum Alfa 100 mg/mlAlexion Pharma GmbHAGtell a friend
  IPCIPPStrensiq 100 mg/ml PRPRk.A.Injection solution: Asfotasum Alfa 100 mg/mlAlexion Pharma GmbHAGtell a friend
  IPCIPPStrensiq 100 mg/ml12PRPRk.A.Injection solution: Asfotasum Alfa 100 mg/mlAlexion Pharma GmbHAGtell a friend
  IPCIPPStrensiq 100 mg/ml12PRPRk.A.Injection solution: Asfotasum Alfa 100 mg/mlAlexion Pharma GmbHAGtell a friend
  IPCI Xylo-Mepha Plus10 mlPRPRk.A.Nasal spray: 2 Active AgentsMepha Pharma AGDGtell a friend
  IPCIPhCMTraumalix dolo patch5PRPRk.A.Patch: Capsici Extractum Ethanolicum Liquidum 86.4 mgDrossapharm AGDGtell a friend
  IPCIPhCMTraumalix dolo patch10PRPRk.A.Patch: Capsici Extractum Ethanolicum Liquidum 86.4 mgDrossapharm AGDGtell a friend
  IP  Oxycodon-Naloxon-Mepha 30
mg/15 mg		30PRPRk.A.Delayed release tablets: 2 Active AgentsMepha Pharma AGA+Gtell a friend
  IP  Oxycodon-Naloxon-Mepha 30
mg/15 mg		60PRPRk.A.Delayed release tablets: 2 Active AgentsMepha Pharma AGA+Gtell a friend
  IPCI Candesartan Spirig HC 4 mg71.505.80k.A.Tablets: Candesartanum Cilexetilum 4 mgSpirig HealthCare AGBGtell a friend
  IPCI Candesartan Spirig HC 8 mg286.7515.95k.A.Tablets: Candesartanum Cilexetilum 8 mgSpirig HealthCare AGBGtell a friend
  IPCI Candesartan Spirig HC 8 mg9822.1541.85k.A.Tablets: Candesartanum Cilexetilum 8 mgSpirig HealthCare AGBGtell a friend
  IPCI Candesartan Spirig HC 16 mg288.1517.55k.A.Tablets: Candesartanum Cilexetilum 16 mgSpirig HealthCare AGBGtell a friend
  IPCI Candesartan Spirig HC 16 mg9828.8049.45k.A.Tablets: Candesartanum Cilexetilum 16 mgSpirig HealthCare AGBGtell a friend
  IPCI Candesartan Spirig HC 32 mg2812.3526.50k.A.Tablets: Candesartanum Cilexetilum 32 mgSpirig HealthCare AGBGtell a friend
  IPCI Candesartan Spirig HC 32 mg9840.7063.10k.A.Tablets: Candesartanum Cilexetilum 32 mgSpirig HealthCare AGBGtell a friend
   CI Selomida Haut30 x 7.5 gPRPRk.A.Pulver zur Herstellung einer Lösung zum Einnehmen: 3 Active AgentsSchwabe Pharma AGDGtell a friend
   CIHSelomida Muskeln12 x 7.5 gPRPRk.A.Pulvermischung: 5 Active AgentsOmida AGDGtell a friend
   CIHSelomida Muskeln30 x 7.5 gPRPRk.A.Pulvermischung: 5 Active AgentsOmida AGDGtell a friend
   CI Selomida Verdauung12 x 7.5 gPRPRk.A.Pulvermischung: 6 Active AgentsSchwabe Pharma AGDGtell a friend
   CI Selomida Verdauung30 x 7.5 gPRPRk.A.Pulvermischung: 6 Active AgentsSchwabe Pharma AGDGtell a friend
   CIHHeidak Nervosität und
Überlastung		30 mlPRPRk.A.Spray zur Anwendung in der Mundhöhle: 6 Active AgentsHeidak AGDGtell a friend
   CIHHeidak Schlafstörungen30 mlPRPRk.A.Spray zur Anwendung in der Mundhöhle: 6 Active AgentsHeidak AGDGtell a friend
  IP  ChloraPrep incolore1.5 mlPRPRk.A.solution pour application cutanée avec applicateur: 2 Active AgentsBD Switzerland Sàrl
Business Park Terre-
Bonne, Bâtiment A4		DGtell a friend
  IP  ChloraPrep incolore3 mlPRPRk.A.solution pour application cutanée avec applicateur: 2 Active AgentsBD Switzerland Sàrl
Business Park Terre-
Bonne, Bâtiment A4		DGtell a friend
  IP  ChloraPrep incolore10.5 mlPRPRk.A.solution pour application cutanée avec applicateur: 2 Active AgentsBD Switzerland Sàrl
Business Park Terre-
Bonne, Bâtiment A4		DGtell a friend
  IP  ChloraPrep incolore26 mlPRPRk.A.solution pour application cutanée avec applicateur: 2 Active AgentsBD Switzerland Sàrl
Business Park Terre-
Bonne, Bâtiment A4		DGtell a friend
  IP  ChloraPrep incolore20 x 1.5 mlPRPRk.A.solution pour application cutanée avec applicateur: 2 Active AgentsBD Switzerland Sàrl
Business Park Terre-
Bonne, Bâtiment A4		DGtell a friend
  IP  ChloraPrep incolore25 x 1.5 mlPRPRk.A.solution pour application cutanée avec applicateur: 2 Active AgentsBD Switzerland Sàrl
Business Park Terre-
Bonne, Bâtiment A4		DGtell a friend
  IP  ChloraPrep incolore60 x 1 mlPRPRk.A.solution pour application cutanée avec applicateur: 2 Active AgentsBD Switzerland Sàrl
Business Park Terre-
Bonne, Bâtiment A4		DGtell a friend
  IP  ChloraPrep incolore25 x 3 mlPRPRk.A.solution pour application cutanée avec applicateur: 2 Active AgentsBD Switzerland Sàrl
Business Park Terre-
Bonne, Bâtiment A4		DGtell a friend
  IP  ChloraPrep incolore25 x 10.5 mlPRPRk.A.solution pour application cutanée avec applicateur: 2 Active AgentsBD Switzerland Sàrl
Business Park Terre-
Bonne, Bâtiment A4		DGtell a friend
 show caption
 
ATC-Browser | Drugs A-Z | Recent Registrations
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home